Norovirus Vaccine against Experimental Human Norwalk Virus Illness

2011486 citationsJournal Articlebronze Open Access

Authors

Robert L. Atmar · Baylor College of Medicine

David I. Bernstein · University of Cincinnati

Clayton Harro · Johns Hopkins University

Mohamed Al‐Ibrahim · Endocrinology Research Center

Wilbur H. Chen · University of Maryland, College Park

Jennifer Ferreira · Emmes (United States)

Mary K. Estes

Abstract

This norovirus VLP vaccine provides protection against illness and infection after challenge with a homologous virus. (Funded by LigoCyte Pharmaceuticals and the National Institutes of Health; ClinicalTrials.gov number, NCT00973284.).

Topics & Keywords

Viral gastroenteritis research and epidemiology Respiratory viral infections research Virus-based gene therapy research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 365, Issue 23, pp. 2178-2187

DOI: 10.1056/nejmoa1101245

Field-Weighted Citation Impact: 23.94